Herbals have been our go-to remedy for thousands of years, so why is it that we still know so little about their side-effects compared to modern medicines?


In this long reads episode, author Daniele Sartori elaborates further on the themes of his Uppsala Reports article on the issue of lack of research on herbal medicines. In his discussion with Drug Safety Matters podcast host Federica Santoro, Daniele covers potential solutions to this problem, such as how to encourage safety data collection for herbals, and how to improve nomenclature and regulation of herbals.

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance news site, brought to you in audio format. Find the original article here. Subscribe by visiting the Drug Safety Matters website.

You may also like


Pharmacovigilance of a high-risk drug: Can AI save us?

An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.

30 March 2026

Underreporting in pharmacovigilance: Where do we go from here?

While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions

18 February 2026

Safe by perception, risky in practice? What vitamin B6 and turmeric teach us about complementary medicines

Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.

07 April 2026